Chunjin B. Ke
No. 1095, Jiefang Road
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Lymphocyte subsets: new hope for noninvasive biomarkers of prostate cancer.
Journal: Journal of leukocyte biology
Published: December 11, 2025
Nuclear Factor Erythroid 2-Related Factor 2 Negatively Regulates Docetaxel-Induced Ferroptosis in Castration-Resistant Prostate Cancer Cells.
Journal: The world journal of men's health
Published: September 14, 2025
Risk factors and therapeutic significance of HER2 overexpression in urothelial carcinoma.
Journal: Pathology, research and practice
Published: July 10, 2024
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 22, 2024
UroVysion™ fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages.
Journal: Frontiers in molecular biosciences
Published: June 30, 2023
The diagnostic value of fluorescence in situ hybridization in secondary electroresection of bladder cancer.
Journal: Bladder (San Francisco, Calif.)
Published: January 19, 2023
Preoperative accuracy of diagnostic evaluation of urachal carcinoma.
Journal: Cancer medicine
Published: November 01, 2022
Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guérin perfusion in bladder cancer.
Journal: Translational cancer research
Published: May 14, 2022
Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study.
Journal: Applied bionics and biomechanics
Published: March 04, 2022
Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.
Journal: Frontiers in oncology
Published: November 20, 2021
Last Updated: 09/26/2026